About Aarti Drugs Ltd
Aarti Drugs is primarily involved in manufacturing and marketing of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals.
Founded
1984
CEO
Chandrakant V. Gogri
Employees
2,865
HQ
Mumbai, India
Finished Products
1Sales
₹6,901.25Cr2Scrap Sale and Others
₹21.86Cr3Export Benefits/Incentives Rec
₹15.43CrRaw Materials
1Raw Material Consumed
₹3,066.90Cr2Packing materials
₹49.90Cr3Purchases of Stock in Trade
₹47.01Cr4Purchase of Trading goods
₹35.86CrAbout Aarti Drugs Ltd
Aarti Drugs is primarily involved in manufacturing and marketing of Active Pharmaceutical Ingredients (API), Pharma Intermediates and Specialty Chemicals.
Founded:1984
CEO:Chandrakant V. Gogri
Employees:2,865
HQ:Mumbai, India
Finished Products
1Sales
₹6,901.25Cr2Scrap Sale and Others
₹21.86Cr3Export Benefits/Incentives Rec
₹15.43CrRaw Materials
1Raw Material Consumed
₹3,066.90Cr2Packing materials
₹49.90Cr3Purchases of Stock in Trade
₹47.01Cr4Purchase of Trading goods
₹35.86CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹535
52W Low
₹319
Volume170.81K
Avg VolumeN/A
Beta0.89
Dividend Yield0.48%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
19.93x
Valuation
P/B Ratio
2.46x
Valuation
EPS
₹20.94
Valuation
Dividend Yield
0.48%
Valuation
ROE
12.58%
Profitability
ROCE
11.51%
Profitability
Revenue by Segment
Contribution & growth by business line
Manufacturing of APIRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
100.0%
International
0.0%
India63.7%
Out of India36.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.37x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-4.2%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.